US › Healthcare

LENSAR Inc (LNSR)

US · Healthcare · Medical Devices

$5.58+3.72%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$13.4M
Revenue YoY
-5.2%
Net profit
$36.3M
Profit YoY
+232.9%
EPS
$-0.20
EPS estimate
$0.49
Net margin
270.6%

EPS came in at -0.20 against a street estimate of 0.49 — a miss of 140.1%.

Key statistics

Market cap
$61.5M
Forward P/E
0.0
P/B
5.73
Book value
$0.89
EPS (TTM)
$-0.55
52-week high
$13.20
52-week low
$4.95
50-day MA
$5.78
200-day MA
$8.82
Beta
0.87

Analyst view

Analysts rate LENSAR Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $8.50.

Shareholding

Insiders
21.53%
Institutions
51.44%

Largest institutional holders

FundStake
Brandes Investment Partners & Co8.35%
BlackRock Inc5.12%
Vanguard Capital Management, LLC3.18%
Geode Capital Management, LLC1.87%
Dimensional Fund Advisors, Inc.1.83%
Css LLC1.33%
Kerrisdale Advisers, LLC1.14%
State Street Corp1.11%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for LENSAR Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.